FDA OKs Raptiva drug labeling changes
Thursday, October 16, 2008 - 15:35
in Health & Medicine
WASHINGTON, Oct. 16 (UPI) -- The U.S. Food and Drug Administration says it has approved labeling changes for the psoriasis drug Raptiva, including a warning about infection risks.